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OBJECTIVES This study sought to evaluate the relationship between brain natriuretic peptide (BNP), renal
function, and the severity of congestive heart failure (CHF).
BACKGROUND Both BNP and renal function are prognostic predictors in CHF patients.
METHODS We measured the plasma BNP level in the aortic root and coronary sinus in 366 consecutive
patients with CHF. Estimated glomerular filtration rate (eGFR) by the Cockcroft-Gault
equation was used as an indicator of renal function.
RESULTS By stepwise multivariate analyses, hemodynamic parameters such as left ventricular ejection
fraction (LVEF) and left ventricular end-diastolic pressure (LVEDP) but not eGFR were
independent predictors of a transcardiac increase (coronary sinus-aortic root) in BNP. Regarding
the plasma level of BNP in the aortic root, not only LVEF (p  0.0001) and LVEDP (p 
0.0001) but also eGFR (p 0.0001) were independent predictors. Patients were divided into
two groups, patients with an eGFR 60 ml/min (group 1, n  229) and patients with an
eGFR 60 ml/min (group 2, n  137). There was no difference in LVEF, LVEDP, or the
transcardiac gradient of BNP between the two groups, but the plasma level of BNP in the
aortic root was approximately two-fold greater in group 2 than in the group 1.
CONCLUSIONS These findings suggest that decreased clearance from the kidney contributes to the
elevated BNP in CHF patients with renal dysfunction, especially in patients with an eGFR
60 ml/min. (J Am Coll Cardiol 2006;47:582–6) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.038Cardiology Foundation
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bhe plasma level of brain natriuretic peptide (BNP) is useful
s an objective marker for the diagnosis of congestive heart
ailure (CHF) caused by systolic and diastolic dysfunction
1). A high plasma BNP level provides important prognostic
redictors not only in patients with CHF (2) and acute
oronary syndrome but also in the general population.
lomerular filtration rate (GFR) as well as BNP has been
hown to be related to prognosis in patients with CHF (3).
herefore, the evaluation of BNP and estimated GFR
eGFR) is important to estimate the severity of CHF;
owever, the relationship between eGFR, BNP, and the
everity of CHF has not been fully elucidated.
Plasma BNP is regulated by secretion from the heart
nd clearance from the circulation. The kidney is an
mportant clearance organ for circulating BNP. To date,
here has not been any report showing a direct relationship
etween renal function and cardiac BNP secretion in CHF
atients. The present study evaluates whether renal function
irectly contributes to the elevated BNP in CHF patients
nd whether other factors such as age, gender, body mass
From Cardiovascular and Respiratory Medicine, Shiga University of Medical
cience, Otsu, Japan. This study was supported by a Grant-in-Aid for Scientific
esearch in Japan.c
Manuscript received June 5, 2005; revised manuscript received October 5, 2005,
ccepted October 10, 2005.ndex, anemia, and atrial fibrillation affect BNP secretion
rom the failing heart in CHF patients.
ETHODS
atients. The patients were 366 consecutive symptomatic
HF patients. Patients with acute myocardial infarction or
hose on dialysis therapy were excluded. Informed consent
as obtained from all patients for participation in the study,
fter protocol approval by the Committee on Human
nvestigation at our institution.
tudy protocol. Blood samples for measuring plasma BNP
ere collected simultaneously from the aortic root and coro-
ary sinus. Renal function was represented by the eGFR
ccording to the Cockroft-Gault equation. Plasma BNP
oncentrations were measured as previously reported (2).
tatistical analysis. All results are expressed as the mean
alues  standard deviation. Chi-square test or analysis of
ariance was used to determine differences between groups.
nivariate analyses were performed using the Student t test.
ecause BNP levels were not normally distributed, differ-
nces between the groups were detected by the Wilcoxon
ank-sum test with two-tailed p values of 0.05, and log
NP was used in correlations and regression models. The
ifference of the intercept of the linear regression line
etween two groups was analyzed using analysis of
ovariance. A p value 0.05 was regarded as significant.
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atient characteristics. Table 1 summarizes the patient
haracteristics according to eGFR.
elationship between plasma BNP and renal function.
here was a significant correlation between the eGFR and
lasma BNP in the aortic root, but there was no significant
orrelation between the eGFR and the transcardiac increase
n BNP (Fig. 1). In Table 2, only the left ventricular ejection
raction (LVEF) and left ventricular end-diastolic pressure
LVEDP) were independent predictors of cardiac BNP
ecretion. In Table 3, not only LVEF and LVEDP but also
able 1. Patient Characteristics
Total
Group 90 < eGFR
haracteristics (n  366) (n  86)
ge, mean (SE), yrs 63.9  12.3 51.7  12.5
ale, n (%) 269 (73) 72 (83)
MI (kg/m2) 23.1  3.7 25.3  4.3
YHA functional class, n (%)
I 45 (12) 6 (7)
II 159 (43) 44 (51)
III 112 (31) 18 (21)
IV 50 (14) 18 (21)
tiology of heart failure
Ischemic cardiomyopathy 227 (62) 46 (54)
Dilated cardiomyopathy 72 (20) 25 (29)
Hypertensive heart disease 67 (18) 15 (17)
Hypertension, n (%) 188 (51) 38 (44)
Diabetes mellitus, n (%) 109 (30) 23 (27)
Heart rate, beats/min 70.1  15.7 73.7  17
Mean blood pressure, mm Hg 91.3  16.5 92.2  16.0
LVEF, % 38.6  11.2 36.2  11.8
LVEDP, mm Hg 12.2  6.5 12.2  6.1
Creatinine, mg/dl 1.05  0.84 0.72  0.15
eGFR, ml/min 72.1  32.9 117.3  26.7
BNP in the AO, pg/ml 189.8  305 125  169
Median value 94 67.9
(CS-AO) BNP, pg/ml 228.9  250 231  274
Median value 150 155
Hemoglobin, g/dl 12.3  1.9 13.6  1.9
reatments
Spironolactone, n (%) 87 (24) 19 (22)
Loop diuretics, n (%) 142 (39) 24 (28)
Digitalis, n (%) 78 (21) 21 (24)
ACEI or ARB, n (%) 245 (67) 58 (68)
Beta-blockers, n (%) 132 (36) 27 (31)
CEI  angiotensin-converting enzyme inhibitor; AO  aortic root; ARB  an
Abbreviations and Acronyms
BNP  brain natriuretic peptide
CHF  congestive heart failure
CKD  chronic kidney disease
eGFR  estimated glomerular filtration rate
GFR  glomerular filtration rate
LVEDP  left ventricular end-diastolic pressure
LVEF  left ventricular ejection fractionS  coronary sinus; eGFR  estimated glomerular filtration rate; LVEDP  left ventricu
ork Heart Association.GFR and hemoglobin were independent predictors of
lasma BNP in the aortic root.
orrelation between hemodynamics and BNP: impact
f renal function. There was no difference in LVEF,
VEDP, and the transcardiac gradient of BNP between the
wo groups, but the plasma level of BNP in the aortic root
as approximately two-fold greater in the group 2 than in
roup 1 (Fig. 2). There were significant correlations be-
ween LVEDP, LVEF, and the transcardiac increase in
NP in both groups with the same regression line (Fig. 3A).
he regression line between the LVEDP, LVEF, and log
NP in the aortic root of patients in group 2 showed a shift
ignificantly upward compared with that of patients in
roup 1 (p  0.001) (Fig. 3B). Figure 4 shows the effect of
he interaction between New York Heart Association func-
ional class and renal function on BNP level. The transcar-
iac increase in BNP was increased with the severity of
HF, but was not affected by the degree of renal function,
hereas the plasma level of BNP was increased with the
everity of CHF and was also independently affected by the
egree of renal function (p  0.001, on two-way analysis of
ariance).
< eGFR <90 40 < eGFR <60 eGFR <40 p Value
(n  143) (n  89) (n  48)
64.1  9.6 71.7  6.0 71.0  10.9 0.0001
108 (75) 58 (65) 31 (65) 0.05
23.2  3.0 21.8  3.2 21.7  3.2 0.0001
0.05
21 (15) 12 (13) 4 (8)
52 (36) 41 (46) 21 (44)
51 (36) 27 (30) 9 (19)
19 (13) 9 (10) 14 (29)
89 (62) 65 (72) 27 (56) 0.05
28 (29) 14 (17) 5 (11) 0.05
26 (18) 10 (11) 16 (33) 0.05
77 (54) 43 (48) 30 (62) 0.188
40 (28) 27 (30) 19 (40) 0.437
68.4  15.7 66.5  12.4 75.6  17.1 0.0004
91.4  16.2 90.6  14.1 90.6  22.1 0.917
38.9  11.6 40.1  9.5 38.8  11 0.127
12.1  6.4 11.3  5.9 14.1  8.2 0.109
0.85  0.17 0.97  0.25 2.45  1.7 0.0001
73.7  8.6 51.1  5.5 26.0  10.2 0.0001
157  185 165  248 450  608
92.2 80 223.5 0.0001
219  217 207  224 295  47
156.8 132 200 0.342
12.6  1.5 11.6  1.7 10.7  1.9 0.0001
30 (21) 21 (23) 17 (35) 0.252
52 (36) 33 (36) 33 (69) 0.0001
30 (21) 12 (13) 15 (31) 0.082
102 (71) 60 (66) 25 (52) 0.121
57 (40) 34 (37) 14 (29) 0.405
sin receptor blocker; BMI  body mass index; BNP  brain natriuretic peptide;60
gioten
lar end-diastolic pressure; LVEF  left ventricular ejection fraction; NYHA  New
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BNP as a Cardiorenal Marker in CHF February 7, 2006:582–6ISCUSSION
he relationship among BNP, renal function, and the
everity of CHF has remained unclear because there has not
een a study examining cardiac BNP secretion in CHF
atients with renal insufficiency. The present study has
uggested the following: 1) If we evaluate the severity of
igure 1. Relationship between the estimated glomerular filtration rate (eG
NP in the aortic root (AO). CS  coronary sinus.
Table 2. Univariate and Multivariate Linear M
Variables
Univariate
Correlation Coef
Age 0.166
Gender (male  1) 0.059
BMI 0.130
Ischemic etiology (yes  1) 0.178
NYHA functional class 0.473
Hemoglobin (g/dl) 0.069
eGFR (ml/min) 0.052
Rhythm (AF  1, sinus  0) 0.064
Heart rate (beats/min) 0.209
Mean blood pressure (mm Hg) 0.067
LVEDP (mm Hg) 0.510
LVEF (%) 0.3564
Abbreviations as in Table 1.
Table 3. Univariate and Multivariate Linear M
Variables
Univariate
Correlation Coef
Age 0.031
Gender (male  1) 0.133
BMI 0.158
Ischemic etiology (yes  1) 0.222
NYHA functional class 0.578
Hemoglobin (g/dl) 0.197
eGFR (ml/min) 0.222
Rhythm (AF  1, sinus  0) 0.187
Heart rate (beats/min) 0.195
Mean blood pressure (mm Hg) 0.115
LVEDP (mm Hg) 0.665
LVEF (%) 0.365
Abbreviations as in Table 1.HF by plasma BNP, we should take into account renal alearance in patients with an eGFR 60ml/min. 2) Renal
unction had a more direct effect on circulating BNP than
reviously recognized, as shown in Figure 4. 3) Other
actors such as age, gender, body mass index, and atrial
brillation may not be the major factor of the plasma BNP
f we concomitantly evaluate LVEF, LVEDP, hemoglobin,
and the plasma log brain natriuretic peptide (BNP) secretion and the log
of Transcardiac Increase in Log BNP
t p Value
Multivariate
Beta-Coefficient (SE) p Value
0.0063
0.8137
0.1773
0.0121
0.0001
0.8728
0.5928
0.301
0.0100
0.0001
0.0001 0.040 (0.005) 0.0001
0.0001 0.010 (0.03) 0.0001
of Plasma Log BNP
t p Value
Multivariate
Beta-Coefficient (SE) p Value
0.547
0.018
0.0024
0.0001
0.0001
0.0001 0.029 (0.01) 0.0024
0.0001 0.003 (0.001) 0.0001
0.0003
0.0002
0.0275
0.0001 0.040 (0.003) 0.0001
0.0001 0.007 (0.001) 0.0001FR)odel
ficienodel
ficiennd renal function (eGFR) in CHF patients.
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February 7, 2006:582–6 BNP as a Cardiorenal Marker in CHFigure 2. Comparisons between hemodynamic parameters and brain natriuretic peptide (BNP). The box defines the interquartile range with the median
ndicated by the crossbar. Group 1  patients with an estimated glomerular filtration rate (eGFR) 60 ml/min; group 2  patients with an eGFR 60
l/min. AO  aortic root; CS  coronary sinus; LVEDP  left ventricular end-diastolic pressure; LVEF  left ventricular ejection fraction.igure 3. (A) Relationship between the log brain natriuretic peptide (BNP) secretion and hemodynamic parameters. (B) Relationship between log BNP
n the aortic root (AO) and hemodynamic parameters. Open circles  group 1 patients; cross marks  group 2 patients; solid lines  patients in group
; dotted lines  patients in group 2. There were significant correlations between left ventricular end-diastolic pressure (LVEDP), left ventricular ejection
raction (LVEF), and the transcardiac increase in BNP in both groups with the same regression line (A). The regression line between the LVEDP, LVEF,
nd log BNP in the AO of group 2 showed a significant shift upward compared with that of group 1 (B). CS  coronary sinus.
o
c
R
w
e
e
T
s
r
e
p
f
w
n
C
p
m
t
i
a
m
r
d
e
p
b
C
R
m
o
E
R
1
2
3
4
5
F
( class
a
586 Tsutamoto et al. JACC Vol. 47, No. 3, 2006
BNP as a Cardiorenal Marker in CHF February 7, 2006:582–6McCullough et al. (4) reported for the first time that the
ptimal cutoff for BNP to diagnose CHF should be in-
reased for patients with an eGFR 60 ml/min/1.73 m2.
ecently, Forfia et al. (5) reported that plasma BNP levels
ere approximately four-fold greater in patients with an
GFR 60 ml/min compared with that in patients with an
GFR60 ml/min, despite similar hemodynamic overload.
he present study supports their observations by the direct
ampling of BNP from the coronary sinus and the aortic
oot at cardiac catheterization in 366 CHF patients.
There are several limitations to this study. The data on
chocardiography were not measured, and there were few
atients with an eGFR 30 ml/min, the standard division
or chronic kidney disease (CKD); we included patients
ith an eGFR 40 ml/min. Therefore, further studies are
eeded to confirm our findings.
We are in the midst of a chronic epidemic of CHF and
KD worldwide. Although many previous studies sup-
orted the usefulness of BNP in the diagnosis and manage-
ent of CHF patients, several limitations have been pos-
ulated. Because of the normal decrease in GFR with
ncreasing age, the diagnostic cutoff for BNP depends on
ge. The present study indicates that renal function had a
ore direct effect on circulating BNP than previously
ecognized in CHF patients with CKD. In conclusion,
igure 4. (A) Interaction between New York Heart Association (NYHA)
transcardiac increase of BNP). (B) Interaction between NYHA functional
re shown. Other abbreviations as in Figure 3.ecreased clearance from the kidney contributes to thelevated BNP in CHF patients with CKD, especially in
atients with an eGFR60 ml/min. The plasma BNP may
e a potential cardiorenal marker in CHF patients with
KD.
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